OTC Markets EXMKT - Delayed Quote USD
Delta 9 Cannabis Inc. (DLTNF)
At close: October 11 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
70,652.8740
71,065.3370
63,228.2710
62,291.4360
52,047.0530
--
Cost of Revenue
58,098.4790
56,620.7560
52,349.5820
44,972.1600
34,048.7870
--
Gross Profit
12,554.3950
14,444.5810
10,878.6890
17,319.2760
17,998.2660
--
Operating Expense
27,772.3260
27,937.7450
31,136.9500
24,958.5630
20,765.9180
--
Operating Income
-15,217.9310
-13,493.1640
-20,258.2610
-7,639.2870
-2,767.6520
--
Net Non Operating Interest Income Expense
-6,755.5980
-6,784.6620
-6,979.3580
-4,268.7850
-3,154.2140
--
Other Income Expense
3,567.0910
3,642.1950
-599.3310
364.8300
837.6810
--
Pretax Income
-18,406.4380
-16,635.6310
-27,836.9500
-11,543.2420
-5,084.1850
--
Tax Provision
--
--
--
-401.0150
401.0150
--
Net Income Common Stockholders
-19,598.0890
-17,515.3390
-27,200.5570
-11,177.4870
-6,417.5250
--
Diluted NI Available to Com Stockholders
-19,598.0890
-17,515.3390
-27,200.5570
-11,177.4870
-6,417.5250
--
Basic EPS
-0.10
--
-0.22
-0.11
-0.07
0.12
Diluted EPS
-0.10
--
-0.22
-0.11
-0.07
0.12
Basic Average Shares
198,048.6370
--
126,067.0440
103,343.8760
89,425.9960
87,299.0710
Diluted Average Shares
198,048.6370
--
126,067.0440
103,343.8760
89,425.9960
89,566.2410
Total Operating Income as Reported
-15,239.4000
-13,493.1640
-20,258.2610
-7,639.2870
-2,767.6520
--
Rent Expense Supplemental
--
--
--
--
--
339.2380
Total Expenses
85,870.8050
84,558.5010
83,486.5320
69,930.7230
54,814.7050
--
Net Income from Continuing & Discontinued Operation
-19,598.0890
-17,515.3390
-27,200.5570
-11,177.4870
-6,417.5250
--
Normalized Income
-19,456.0890
-17,437.3390
-26,288.5610
-11,177.4870
-6,559.5718
--
Interest Income
20.1290
21.2540
116.7100
31.1200
44.1580
--
Interest Expense
6,775.7270
6,805.9160
6,601.6020
3,898.9100
3,198.3720
--
Net Interest Income
-6,755.5980
-6,784.6620
-6,979.3580
-4,268.7850
-3,154.2140
--
EBIT
-11,630.7110
-9,829.7150
-21,235.3480
-7,644.3320
-1,885.8130
--
EBITDA
-2,995.4880
-1,042.3720
-13,268.9400
-1,169.2510
3,429.1130
--
Reconciled Cost of Revenue
57,927.9570
56,450.5370
52,229.3780
44,825.3720
32,334.0620
--
Reconciled Depreciation
8,635.2230
8,787.3430
7,966.4080
6,475.0810
5,314.9260
--
Net Income from Continuing Operation Net Minority Interest
-19,598.0890
-17,515.3390
-27,200.5570
-11,177.4870
-6,417.5250
--
Total Unusual Items Excluding Goodwill
-142.0000
-78.0000
-911.9960
--
193.2610
--
Total Unusual Items
-142.0000
-78.0000
-911.9960
--
193.2610
--
Normalized EBITDA
-2,853.4880
-964.3720
-12,356.9440
-1,169.2510
3,235.8520
--
Tax Rate for Calcs
--
--
--
0.0000
0.0003
--
Tax Effect of Unusual Items
--
--
--
--
51.2142
--
12/31/2019 - 11/6/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
STHZ.CN StateHouse Holdings Inc.
0.0300
0.00%
MJMJ.CN Vertical Peak Holdings Inc.
0.0050
0.00%
LUFFF Herbal Dispatch Inc.
0.1000
0.00%
DHBUF Delivra Health Brands Inc.
0.0181
-9.50%
AUSAF Australis Capital Inc.
0.0001
0.00%
CNTTQ CannTrust Holdings Inc.
0.0000
0.00%
AUSA.CN Australis Capital Inc.
0.0250
0.00%
MEDIF MediPharm Labs Corp.
0.0530
+4.33%
AAWH Ascend Wellness Holdings, Inc.
0.7850
+1.95%
PHRX.CN Pharmadrug Inc.
0.0200
0.00%